<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This chapter demonstrates the use of <z:chebi fb="199" ids="26708">sodium</z:chebi> magnetic resonance imaging (MRI) as a noninvasive, in vivo means to assess metabolic changes that ensue from <z:mp ids='MP_0000340'>loss of cell</z:mp> ion homeostasis due to cell <z:hpo ids='HP_0011420'>death</z:hpo> in the brain </plain></SENT>
<SENT sid="1" pm="."><plain>The chapter is organized in two sections </plain></SENT>
<SENT sid="2" pm="."><plain>In the first section, the constraints imposed on the imaging methods by the nuclear magnetic resonance (NMR) properties of the <z:chebi fb="33" ids="29101">sodium ion</z:chebi> are discussed and strategies for avoiding their potential limitations are addressed </plain></SENT>
<SENT sid="3" pm="."><plain>The second section illustrates the use of <z:chebi fb="199" ids="26708">sodium</z:chebi> MRI for monitoring focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> in permanent and temporary primate models of endovascular middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
</text></document>